ClinicalTrials.gov record
An Exploratory Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Three Different Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III)
COMPLETED · NCT06556056
Trial record
NCT IDNCT06556056
Status
COMPLETED
Study type
INTERVENTIONAL
Phase
NA
Enrollment
108
Conditions
Androgenic Alopecia
Interventions
SesZen-Bio Serum, Minoxidil hair serum (1%), Placebo, Liposomal Form of SesZenBio, Minoxidil Hair Serum (5%), SesZen-Bio Serum + SesZen-Bio 350 mg extract
Locations
NovoBliss Research Private Limited, Ahmedabad, Gujarat, India
Indexed topics
Last update
2025-09-02